BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$2.18
+0.09 (+4.31%)
As of May 10, 10:41 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +666.5% upside
Low Target $12.81
Average Target $16.71
High Target $20.08
Current Price $2.18
Current
$2.18
Target
$16.71
$12.81 $16.71 avg $20.08
Scenario Analysis
Bear Case
$12.81
487.6%
Low target
Base Case
$16.71
+666.5%
Avg target
Bull Case
$20.08
+821.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.75
-54.1% from high
52-Week Low
$1.27
+71.7% from low
Target vs 52W High
$16.71
+251.8% vs high
Next Earnings Report
May 12, 2026
Today
EPS Est: $0.05
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%